Transduction of nondividing human macrophages with gammaretrovirus-derived vectors

Loraine Jarrosson-Wuilleme1, Caroline Goujon, Jeanine Bernaud

  • 1LaboRetro, INSERM U412, Ecole Normale Supérieure de Lyon, IFR 128 BioSciences Lyon-Gerland, 46 Allée d'Italie, 69364 Lyon, France.

Journal of Virology
|January 18, 2006
PubMed

Insights

Gammaretroviruses typically cannot infect nondividing cells. However, human macrophages become susceptible to Friend murine leukemia virus (F-MLV) vector transduction during differentiation, opening new gene therapy possibilities.

Area of Science:

  • Virology
  • Cell Biology
  • Gene Therapy

Background:

  • Gammaretroviruses, like murine leukemia viruses, are generally inefficient at infecting nondividing cells.
  • This inefficiency is often attributed to the inability of these viruses to cross the nuclear envelope barrier.

Purpose of the Study:

  • To challenge the notion that nondividing cells are completely resistant to gammaretroviral infection.
  • To investigate the susceptibility of human macrophages to gammaretroviral vectors during differentiation.

Main Methods:

  • Utilized a Friend murine leukemia virus (F-MLV)-derived vector for transduction experiments.
  • Focused on human monocyte-derived macrophages during their differentiation process.

Main Results:

  • Demonstrated a specific window of susceptibility to F-MLV vector transduction in human nondividing macrophages.
  • Identified that macrophage differentiation influences permissiveness to gammaretroviral infection.

Conclusions:

  • Nuclear membrane crossing is not the sole determinant of gammaretroviral infection permissiveness in nondividing cells.
  • The macrophage tropism of F-MLV vectors presents potential applications in gene therapy.

Related Concept Videos